My Top Nuclear Stock to Buy Right Now (and It's Not Even Close)

Nuclear power is seeing a resurgence, with Goldman Sachs and Morgan Stanley pointing to small modular reactors (SMRs) as the key scaling pathway amid rising electricity demand for data centers and AI. NuScale Power is highlighted as the only U.S.-regulator-cleared SMR builder, with a prospective Tennessee Valley Authority deal for a 6-gigawatt system (potentially 30x the largest existing SMR), but the article stresses no final financial commitments and a power purchase agreement not expected until end-2026. Despite a cited ~90% valuation discount versus peers (e.g., OKLO), largely due to prior customer cancellation in 2023, the piece frames the setup as high-risk/high-reward for risk-tolerant investors.

Analysis

The equity market is likely to misprice the timing here: the real economic bottleneck is not “whether nuclear is needed,” but who can deliver firm megawatts on an acceptable financing timeline. That means the first-order winners over the next 1-3 months are likely to be power-adjacent names with tangible projects, grid equipment, and financing franchises, while pure-play SMR developers remain mostly option value until an off-take agreement and project finance package are visible. In that framework, SMR and OKLO are trading as long-duration call options on a multi-year buildout, not as near-term earnings compounds.

Second-order, the most important substitution effect is that AI load growth will probably be met first by gas turbines, transmission upgrades, and regulated utility capex because those are faster to deploy and easier to finance. If that substitution persists, the “nuclear renaissance” narrative can stay alive while developer equities still underperform on a cash-flow basis; higher rates would exacerbate that divergence by compressing the present value of very distant cash flows. For the banks, the better trade is not the reactor narrative itself but the financing/advisory tollbooth if project pipelines mature.

Contrarian view: consensus is treating regulatory clearance as a commercialization inflection, but the market still has to bridge the gap from permissibility to bankability. The key falsifier is not another bullish report; it is a delay in binding offtake or a failure to show committed capital over the next 6-18 months. If those milestones slip, the rerating in SMR names should fade quickly, especially if broader risk assets de-rate or real yields stay elevated.

Key Decisions for Investors

• Avoid chasing SMR/OKLO after narrative spikes; wait for a confirmed PPA/financing announcement before taking directional exposure. If no binding capital structure emerges into mid-2026, treat the stocks as fading call options rather than fundamentals.
• Pair trade: short SMR or OKLO against a basket of utility/grid proxies (e.g., XLU or industrial power equipment names) for 1-3 months. Thesis: the market will overpay for far-dated SMR optionality while near-term load growth is captured by faster-to-build infrastructure.
• Small tactical long GS/MS only as a financing-optionality trade, not a nuclear beta trade. Best entry is on project-approval headlines that increase the probability of underwriting, syndication, and project finance fees over the next 6-12 months.
• Use call spreads, not outright shares, if expressing bullishness in SMR. The setup is high convexity but poor carry; define risk around the next missed financing milestone or any rate-driven de-rating in long-duration equities.